Positive association between miR-499a>G and hepatocellular carcinoma risk in a chinese population

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1769-1772

  Zou, Hong Zhi ^a   Zhao, Yan Qiu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Chinese population; Hepatocellular carcinoma; miR 499A>G; Susceptibility

Indexed keywords

EID: 84880438195     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1769     Document Type: Article

References (27)

1. Akkiz H, Bayram S, Bekar A, et al (2011). A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat, 18, e399-407.
2. Akkiz H, Bayram S, Bekar A, et al (2011). Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev, 12, 3107-12.
3. Aumiller V, Forstemann K (2008). Roles of microRNAs beyond development- metabolism and neural plasticity. Biochim Biophys Acta, 1779, 692-6.
4. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
5. Dimmeler S, Nicotera P (2013). MicroRNAs in age-related diseases. EMBO Mol Med, 5, 180-90.
6. El Serag HB (2011). Hepatocellular carcinoma. N Engl J Med, 365, 1118-27.
7. Gao LB, Bai P, Pan XM, et al (2011). The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 125, 571-4.
8. Zu Z, Liang J, Wang Z, et al (2009). Common genetic variants in pre-microRNAs were as-sociated with increased risk of breast cancer in Chinese women. Hum Mutat, 30, 79-84. International Agency for Research on Cancer. Liver cancer incidence and mortality worldwide in 2011; http://globocan. iarc.fr/factsheets/cancers/liver.asp. 2008.
9. International Agency for Research on Cancer. Liver cancer incidence and mortality worldwide in 2011; http://globocan. iarc.fr/factsheets/cancers/liver.asp. 2008.
10. Johnnidis JB, Harris MH, Wheeler RT, et al (2008). Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature, 451, 1125-9.
11. Kloosterman WP, Plasterk RH (2006). The diverse functions of microRNAs in animal development and disease. Dev Cell, 11, 441-50.
12. Liu Z, Li G, Wei S, et al (2010). Genetic variants in selected preHong- Zhi Zou and Yan-Qiu Zhao 1772 Asian Pacific Journal of Cancer Prevention, Vol 14, 2013 microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer, 116, 4753-60.
13. Lu X, Zhao P, Zhang C, Fu Z, et al (2009). Analysis of miR-221 and p27 expression in human gliomas. Mol Med Report, 2, 651-6.
14. Perz JF, Armstrong GL, Farrington LA, et al (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol, 45, 529-38.
15. Okubo M, Tahara T, Shibata T, et al (2010). Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter, 15, 524-31.
16. Osada H, Takahashi T (2007). MicroRNAs in biological processes and carcinogenesis. Carcinogenesis, 28, 2-12.
17. Ouyang YB, Stary CM, Yang GY, et al (2013). microRNAs: Innovative Targets for Cerebral Ischemia and Stroke. Curr Drug Targets, 14, 90-101.
18. Qiu MT, Hu JW, Ding XX, et al (2012). Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PLoS One, 7, e50887.
19. Ryan BM, Robles AI, Haris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer, 10, 389-402.
20. Srivastava K, Srivastava A, Mittal B (2010). Common genetic variants in pre-microRNAs and risk of gallbladder can-cer in North Indian population. J Hum Genet, 55, 495-99.
21. Srivastava K, Srivastava A (2012). Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One, 7, e50966. Stefani G, Slack FJ (2008). Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol, 9, 219-30.
22. Stefani G, Slack FJ (2008). Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol, 9, 219-30.
23. Xiang Y, Fan S, Cao J, et al (2012). Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep, 39, 7019-23.
24. Xu T, Zhu Y, Wei QK, et al (2008) A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis, 29, 2126-31.
25. Zhou B, Wang K, Wang Y, et al (2011). Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog, 50, 499-505.
26. Zhou J, Lv R, Song X, et al (2012). Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol, 31, 524-30.
27. Zhou M, Liu Z, Zhao Y, et al (2010). MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem, 285, 21496-507.